875-21808-00711
2 vaccinations
8 coded responses
22 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 295 / SC
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
-
2021-03-11
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal pain, Renal pain — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Mid-drift abdominal to kidney painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-13
Survey response — days 1–6 daily, dose 1MedDRA: Eye pain, Headache — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Un-usual severe left eye socket pain(considered head)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Myalgia, Neck pain, Pain in extremity — Feeling: GoodFree text: Left hip, right neck/arm joint/muscle painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Headache, Joint painsFree text: Head last night, head right neck/shoulderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Survey response — day 7, dose 1MedDRA: Insomnia — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: SleeplessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-31
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Joint pains, Muscle or body achesAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-04-08
- 2021-04-15
- 2021-04-23
- 2021-04-29
- 2021-05-06
-
2021-05-13
Survey response — day 42, dose 2MedDRA: Rash, Skin exfoliation — Feeling: GoodFree text: Scaley places in and above eyebrows, sides of nose & mouth. Seems to begin really teeny tiny and fluid filled then turns scaley for the past few weeks. Never seen before & not going away.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-01
-
2021-09-30
Survey response — 6 months, dose 2MedDRA: Arthralgia, Arthritis, Circadian rhythm sleep disorder, Diarrhoea, Exposure to SARS-CoV-2, Fatigue, Insomnia, Nausea, Patient isolation, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Isolated 14 days after exposure to Covid-19 in August 2021.*experienced low grade fever, nausea, diarrhea, fatigue, sleeplessness with extreme exhaustion, joint inflammation pain.*Currently my circadian rhythm is extremely off balance.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Survey response — 12 months, dose 2MedDRA: Immunisation reaction, Malaise, Pain, Pyrexia, Respiratory distress, SARS-CoV-2 test negative, Self-medication — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Respiratory distress, fever, pain. Seems had a severe reaction to 2nd booster. I'm 57 y/o, 63 lbs, 4' 8 tall. Discovered I'm not eligible for monoclonal antibodies treatment being under 86 pounds. · Healthcare visit (other): Covid-19 testing negative with positive symptoms. Told OTC for fever and pain. Nebulizer and inhaler for respiratory distress.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Mid-drift abdominal to kidney pain
Systemic reaction (other): Un-usual severe left eye socket pain(considered head)
Systemic reaction (other): Left hip, right neck/arm joint/muscle pain
Systemic reaction (other): Head last night, head right neck/shoulder
Release 5 — day 7, dose 1
Systemic reaction (other): Sleeplessness
Release 8 — day 42, dose 2
Symptoms: Scaley places in and above eyebrows, sides of nose & mouth. Seems to begin really teeny tiny and fluid filled then turns scaley for the past few weeks. Never seen before & not going away.
Release 9 — 6 months, dose 2
Symptoms: Isolated 14 days after exposure to Covid-19 in August 2021.*experienced low grade fever, nausea, diarrhea, fatigue, sleeplessness with extreme exhaustion, joint inflammation pain.*Currently my circadian rhythm is extremely off balance.
Release 11 — 12 months, dose 2
Symptoms: Respiratory distress, fever, pain. Seems had a severe reaction to 2nd booster. I'm 57 y/o, 63 lbs, 4' 8 tall. Discovered I'm not eligible for monoclonal antibodies treatment being under 86 pounds.
Healthcare visit (other): Covid-19 testing negative with positive symptoms. Told OTC for fever and pain. Nebulizer and inhaler for respiratory distress.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Malaise | · | · | ✓ |
| HCVO | Pain | · | · | ✓ |
| HCVO | Pyrexia | · | · | ✓ |
| HCVO | Respiratory distress | · | · | ✓ |
| HCVO | SARS-CoV-2 test negative | · | · | ✓ |
| HCVO | Self-medication | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Circadian rhythm sleep disorder | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Immunisation reaction | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory distress | · | · | ✓ |
| SD | Skin exfoliation | ✓ | ✓ | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Renal pain | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release